Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Miller

Showing results (131-140 of 162) with videos related to

Pageof 17
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2013
Magnetic resonance imaging outcomes from a phase III trial of teriflunomideJerry S Wolinsky, Ponnada A Narayana, Flavia Nelson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2025
DISCOntinuation of disease-modifying therapies in MS: The DISCOMS extension trialJohn R Corboy, Robert J Fox, Gary Cutter, et al.
Biotechnology and Bioengineering|September 27, 2016
FX knockout CHO hosts can express desired ratios of fucosylated or afucosylated antibodies with high titers and comparable product qualitySalina Louie, Benjamin Haley, Brett Marshall, et al.
Nature Nanotechnology|January 21, 2022
Reversible strain-induced magnetic phase transition in a van der Waals magnetJohn Cenker, Shivesh Sivakumar, Kaichen Xie, et al.
The Journal of Clinical Investigation|November 20, 2012
Mutant huntingtin impairs immune cell migration in Huntington diseaseWanda Kwan, Ulrike Träger, Dimitrios Davalos, et al.
Multiple Sclerosis and Related Disorders|June 2, 2021
Dietary factors and MRI metrics in early Multiple SclerosisI B Katz Sand, Kathryn C Fitzgerald, Yian Gu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 23, 2016
The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosisDiego Cadavid, Jeffrey A Cohen, Mark S Freedman, et al.
Public Health Nursing (Boston, Mass.)|March 24, 2020
Trauma, substance use, and mental health symptoms in transitional age youth experiencing homelessnessCarol Dawson-Rose, Deena Shehadeh, Jennifer Hao, et al.
Archives of Neurology|September 10, 2008
Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patientsAnu Jacob, Brian G Weinshenker, Ivo Violich, et al.
Archives of Biochemistry and Biophysics|March 21, 2003
Glutathione, S-substituted glutathiones, and leukotriene C4 as substrates for peptidylglycine alpha-amidating monooxygenaseLaura Aaron Miller, Laura E Baumgart, Geoffrey H Chew, et al.
Pageof 17

Showing results (131-140 of 162) with videos related to

Sort By:
Pageof 17
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 1, 2013
Magnetic resonance imaging outcomes from a phase III trial of teriflunomideJerry S Wolinsky, Ponnada A Narayana, Flavia Nelson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2025
DISCOntinuation of disease-modifying therapies in MS: The DISCOMS extension trialJohn R Corboy, Robert J Fox, Gary Cutter, et al.
Biotechnology and Bioengineering|September 27, 2016
FX knockout CHO hosts can express desired ratios of fucosylated or afucosylated antibodies with high titers and comparable product qualitySalina Louie, Benjamin Haley, Brett Marshall, et al.
Nature Nanotechnology|January 21, 2022
Reversible strain-induced magnetic phase transition in a van der Waals magnetJohn Cenker, Shivesh Sivakumar, Kaichen Xie, et al.
The Journal of Clinical Investigation|November 20, 2012
Mutant huntingtin impairs immune cell migration in Huntington diseaseWanda Kwan, Ulrike Träger, Dimitrios Davalos, et al.
Multiple Sclerosis and Related Disorders|June 2, 2021
Dietary factors and MRI metrics in early Multiple SclerosisI B Katz Sand, Kathryn C Fitzgerald, Yian Gu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 23, 2016
The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosisDiego Cadavid, Jeffrey A Cohen, Mark S Freedman, et al.
Public Health Nursing (Boston, Mass.)|March 24, 2020
Trauma, substance use, and mental health symptoms in transitional age youth experiencing homelessnessCarol Dawson-Rose, Deena Shehadeh, Jennifer Hao, et al.
Archives of Neurology|September 10, 2008
Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patientsAnu Jacob, Brian G Weinshenker, Ivo Violich, et al.
Archives of Biochemistry and Biophysics|March 21, 2003
Glutathione, S-substituted glutathiones, and leukotriene C4 as substrates for peptidylglycine alpha-amidating monooxygenaseLaura Aaron Miller, Laura E Baumgart, Geoffrey H Chew, et al.
Pageof 17